Additive effect of beraprost on pulmonary vasodilation by inhaled nitric oxide in children with pulmonary hypertension

American Journal of Cardiology

Volumn 80, Issue 5, 1997, Pages 662-664

  Ichida, Fukiko ^a   Uese, Kei Ichiro ^a   Tsubata, Shin Ichi ^a   Hashimoto, Ikuo ^a   Hamamichi, Yuji ^a   Fukahara, Kazuaki ^a   Murakami, Arata ^a   Miyawaki, Toshio ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BERAPROST; CYCLIC AMP; CYCLIC GMP; NITRIC OXIDE; PROSTACYCLIN DERIVATIVE;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG POTENTIATION; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; LUNG VASCULAR RESISTANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

CHILD; CHILD, PRESCHOOL; CYCLIC AMP; CYCLIC GMP; DRUG SYNERGISM; EPOPROSTENOL; HUMANS; HYPERTENSION, PULMONARY; INFANT; LUNG; NITRIC OXIDE; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 0030955176     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00447-5     Document Type: Article

References (9)

1. Berner M, Beghetti M, Spahr-Schopfer I, Oberhansli I, Friedli B. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease. Am J Cardiol 1996;77:532-535.
2. Goldman AP, Delius RE, Deanfield JE, Macrae DJ. Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations. Ann Thorac Surg 1995;60:300-306.
3. Day RW, Lynch JM, Shaddy RE, Orsmond GS. Pulmonary vasodilatory effects of 12 and 60 parts per million inhaled nitric oxide in children with ventricular septal defect. Am J Cardiol 1995;75:196-198.
4. Bush A, Busst C, Booth K, Knight WB, Shinebourne EA. Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease? Circulation 1986;74:135-144.
5. Bush A, Busst C, Knight WB, Shineborne EA. Modification of pulmonary hypertension secondary to congenital heart disease by prostacyclin therapy. Am Rev Respir Dis 1987;136:767-769.
6. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization. Circulation 1995;92:3337-3349.
7. Takeo S. Pharmacodynamics and clinical studies with beraprost sodium, a drug for peripheral vascular disease. Cardiovasc Drug Rev 1992;10:392-403.
8. 2 analogue, Beraprost, in primary and secondary pulmonary hypertension. Am J Cardiol 1996;78:244-247.
9. Katz RW, Pollack MM, Weibley RE. Pulmonary artery catheterization in pediatric intensive care. Adv Pediatr 1984;30:169-190.